Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation TVT 2017

Device Design Features and Findings From EU Clinical Trials

Presenter: Joachim Schofer

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presenter: Axel Linke

June 15, 2017

Presentation TVT 2014

A Citizen of the World and Frequent TAVR Proctor

Presenter: Eberhard Grube

June 07, 2014

Presentation TVT 2014

An Interventionalist from London, UK

Presenter: Martyn R. Thomas

June 07, 2014

Presentation TVT 2014

A Surgeon from Dallas, Texas

Presenter: Michael J. Mack

June 07, 2014

Presentation TVT 2014

The Daunting Task of Explaining High TAVR Costs to Practitioners, Hospital Administrators, and Healthcare Systems

Presenter: Larry L. Wood

June 07, 2014

Presentation TVT 2014

Are Reimbursement Patterns Directly Affecting TAVR Clinical Usage in Europe?

Presenter: Nicolo Piazza

June 07, 2014

Presentation TVT 2014

TAVR is not Cost Effective Compared with Surgery (in Most Patients)!

Presenter: A. Pieter Kappetein

June 07, 2014

Presentation TVT 2014

The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies

Presenter: David J. Cohen

June 07, 2014

Presentation TVT 2013

The Case for the Hybrid OR-Cath Lab

Presenter: Michael Reardon

June 14, 2013

Presentation TVT 2013

Advantages and Design Requirements of a Hybrid Cath Lab/OR for TAVR (and Other Complex) Procedures

Presenter: Mathew Williams

June 13, 2013

Presentation TVT 2013

A Standard Cath Lab Is Sufficient for TAVR Procedures: Rouen and FRANCE 2 Experiences

Presenter: Alain Cribier

June 13, 2013

Advertisement

Device Design Features and Findings From EU Clinical Trials

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

A Citizen of the World and Frequent TAVR Proctor

An Interventionalist from London, UK

A Surgeon from Dallas, Texas

The Daunting Task of Explaining High TAVR Costs to Practitioners, Hospital Administrators, and Healthcare Systems

Are Reimbursement Patterns Directly Affecting TAVR Clinical Usage in Europe?

TAVR is not Cost Effective Compared with Surgery (in Most Patients)!

The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies

The Case for the Hybrid OR-Cath Lab

Advantages and Design Requirements of a Hybrid Cath Lab/OR for TAVR (and Other Complex) Procedures

A Standard Cath Lab Is Sufficient for TAVR Procedures: Rouen and FRANCE 2 Experiences

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content